12 Analysts Just Revealed Their Shocking Outlooks on Brunswick: What You Need to Know

September 28, 2024

Brunswick (NYSE: BC) has been under the microscope for financial experts in recent months, and with their diverse evaluations, it's time to dive into their perceptions and identify shifts in market trends. The summary below encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Bullish and Bearish Sentiments

For those unfamiliar with analyst ratings, Brunswick's ratings can be classified as bullish, somewhat bullish, indifferent, somewhat bearish, or bearish. The snapshot of the ratings offers a perspective on the shifts in market trends in the past three months.

  • Bullish: 9
  • Somewhat bullish: 1
  • Indifferent: 0
  • Somewhat bearish: 0
  • Bearish: 2
A closer look reveals Brunswick's current evaluation as slightly less optimistic than in the past, reflecting market uncertainties.

12 Months Price Targets and Analyst Estimates

By examining the analysts' price targets for the next 12 months, we can gain a better understanding of their vision for Brunswick. A $91.17 average target is noted, ranging from a high estimate of $101.00 to a low estimate of $70.00. Furthermore, when compared to the prior average price target of $97.09, the current average shows a 6.1% drop, revealing shifting market conditions.

Recent Analyst Evaluations and Revisions to Price Targets

Notable analyst ratings and subsequent revisions provide further insights into Brunswick. Below are brief details on specific analyst actions that explain the analyst outlook on the company.
  • James Hardiman from Citigroup: The firm has raised Brunswick's rating to buy, with a new price target of $101.00. Hardiman adjusted his rating from buy to reflect a target increase of $92.00 to $101.00. However, he also adjusted his price target downwards from $100.00 to $88.00 a different period in time.
  • John Healy from Northcoast Research: Northcoast Research now rates Brunswick as a buy, listing a price target of $100.00. This revised price target serves as an initiation to their buy rating, from no prior price target on Brunswick.
  • Scott Stember from Roth MKM: Stember adjusted his price target for Brunswick from $94.00 to $91.00, which is still categorized as a buy rating.
  • Michael Albanese from Benchmark: While maintaining Brunswick's buy rating, Michael Albanese has decided to retain a $100.00 price target, with no changes since the last reported evaluation.
  • Anna Glaessgen from Jefferies: Jefferies rated Brunswick as hold with a reduced price target from $115.00 to $70.00, indicating concerns with the company's performance.
  • Craig Kennison from Baird: Kennison has downgraded Brunswick to outperform and reduced the price target to $93.00, an estimation decrease from $95.00.
  • Scott Stember from Roth MKM: Last Stember evaluation in the table maintained a buy rating with an unchanged $94.00 price tag.
  • Kevin Heenan from JP Morgan: JP Morgan reported a downgraded rating to neutral and reduced the estimated price target from $78.00 to $75.00.
  • Drew Crum from Stifel: Drew Crum has reported a buy, slightly decreasing the price target from $97.00 to $95.00 for Brunswick.
  • Eric Wold from B. Riley Securities: Eric Wold downgraded Brunswick to a buy rating and decreased his estimated price target to $97.00 from $108.00.
  • Michael Swartz from Truist Securities: Swartz has adjusted the estimated price target to $90.00, down from $95.00 with a buy rating maintained.
Brunswick remains a notable player in the market, and through this glimpse into the evolving sentiments, a better understanding of the trends in the financial market can be gained. But the insights provided should be factored in a comprehensive and more personal look before making final financial decisions on Brunswick. All further readings of this story are now exclusively available on Benzinga.com

Other articles

Shocking Truth Behind 20-Year Jail Term of Rogue Breast Surgeon Exposed

October 11, 2024

Ian Paterson, a disgraced breast surgeon serving a lengthy 20-year jail term, has declined to give evidence in a series of inquests. The surgeon's ...

Gambhir Stands by Struggling KL Rahul - The Real Reason Behind His Unwavering Support!

October 22, 2024

Despite being a crucial component of the Indian cricket team, KL Rahul finds himself at the receiving end of intense scrutiny following his dismal ...

Shamrock Rovers Leave Larne in the Dust - This 3-0 Thrashing is Just the Beginning!

October 25, 2024

Shamrock Rovers proved their dominance on the field with a resounding 3-0 win over Larne, leaving fans and opponents alike in awe of their impressi...

Every Spooky Family Guy Episode Is Hiding in Plain Sight - Here's How to Uncover Them All

October 15, 2024

The new episode just dropped on Hulu, and it's got everyone rushing to watch the latest addition to the Family Guy Halloween special collection. Wi...

Proteas Women's Shattered Cricket Dreams: Can They Rise Again?

October 22, 2024

The Proteas Women's team has scripted an unforgettable chapter in the history of South African sports, their names etched in the annals of cricketi...